Health economics and nutrition: A review of published evidence

Nutrition Reviews

Volumn 70, Issue 12, 2012, Pages 693-708

  Gyles, Collin L ^a   Lenoir Wijnkoop, Irene ^b   Carlberg, Jared G ^a   Senanayake, Vijitha ^c   Gutierrez Ibarluzea, Inaki ^d   Poley, Marten J ^e   Dubois, Dominique ^f   Jones, Peter J ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b DANONE RESEARCH   (France)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Basque Office for Health Technology Assessment   (Spain)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Dietary improvements; Functional foods; Malnutrition; Micronutrient deficiencies; Nutrition economics

Indexed keywords

BETA CAROTENE; CANOLA OIL; CYANOCOBALAMIN; FAT; FOLIC ACID; IRON; OMEGA 3 FATTY ACID; PHYTOSTEROL; RETINOL; SODIUM CHLORIDE; STANOL ESTER; ZINC;

ANEMIA; BLINDNESS; CALORIE; CARDIOVASCULAR DISEASE; CHILDHOOD MORTALITY; COLON CANCER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DIET; EDUCATION; EXERCISE; FUNCTIONAL FOOD; HEALTH CARE COST; HEALTH ECONOMICS; HEART INFARCTION; HEMOGLOBIN DETERMINATION; HUMAN; INFANT MORTALITY; IODINE DEFICIENCY; IRON DEFICIENCY; ISCHEMIC HEART DISEASE; MALNUTRITION; MATERNAL MORTALITY; MORBIDITY; MORTALITY; NEURAL TUBE DEFECT; NUTRITION; NUTRITIONAL DEFICIENCY; PERINATAL MORTALITY; QUALITY OF LIFE; RETINOL DEFICIENCY; REVIEW; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

COST-BENEFIT ANALYSIS; DEFICIENCY DISEASES; FUNCTIONAL FOOD; HEALTH STATUS; HUMANS; MICRONUTRIENTS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL STATUS;

EID: 84870516770     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00514.x     Document Type: Review

References (88)

1. Lenoir-Wijnkoop I, Dapoigny M, Dubois D, etal. Nutrition economics - characterising the economic and health impact of nutrition. Br J Nutr. 2011;105:157-166.
2. Cawley J. An economic framework for understanding physical activity and eating behaviours. Am J Prev Med. 2004;27:117-125.
3. Byford S, Torgerson D. Economic issues in nutrition research. Nutrition. 1998;14:248-250.
4. Kenkel D, Manning W. Economic evaluation of nutrition policy: Or, there's no such thing as a free lunch. Food Policy. 1999;24:145-162.
5. Liljas B. On the welfare theoretic foundation of cost-effectiveness analysis - the case when survival is not affected. Eur J Health Econ. 2010;11:5-13.
6. Bendich A, Leader S, Muhur IP. Supplemental calcium for the prevention of hip fracture: potential health-economic benefits. Clin Ther. 1999;21:1058-1072.
7. Dalziel K, Segal L. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions. Health Promot Int. 2007;22:271-283.
8. Thow AM, Jan S, Leeder S, etal. The effect of fiscal policy on diet, obesity and chronic disease: a systematic review. Bull World Health Organ. 2010;88:609-614.
9. Fox MK, Hamilton W, Lin B-H. Effects of Food Assistance and Nutrition Programs on Nutrition and Health. Volume 4. Executive Summary of the Literature Review. Food Assistance and Nutrition Research Report No. 19-4. Washington, DC: Economic Research Service, US Department of Agriculture; 2004.
10. Popkin B, Solon F, Fernandez T, etal. Benefit-cost analysis in the nutrition area: a project in the Philippines. Soc Sci Med. 1980;14:207-216.
11. Phillips M, Sanghvi T, Suárez R, etal. The costs and effectiveness of three vitamin A interventions in Guatemala. Soc Sci Med. 1996;42:1661-1668.
12. Loevinsohn B, Sutter R, Costales M. Using cost-effectiveness analysis to evaluate targeting strategies: the case of vitamin A supplementation. Health Policy Plan. 1997;12:29-37.
13. Horton S. The economics of nutritional interventions. Semba R, Bloem M, eds. Nutrition and Health: Nutrition and Health in Developing Countries. Totowa, NJ: Humana Press; 2008:853-871.
14. Sari M, Bloem M, de Pee S, etal. Effect of iron-fortified candies on the iron status of children aged 4-6 y in East Jakarta. Am J Clin Nutr. 2001;73:1034-1039.
15. Horton S, Ross J. The economics of iron deficiency. Food Policy. 2003;28:51-75.
16. Hunt J. Reversing productivity losses from iron deficiency: the economic case. J Nutr. 2002;132:S794-S801.
17. Baltussen R, Knai C, Sharan M. Iron fortification and iron supplementation are cost-effective interventions to reduce iron deficiency in four subregions of the world. J Nutr. 2004;134:2678-2684.
18. Ma G, Jin Y, Li Y, etal. Iron and zinc deficiencies in China: what is a feasible and cost-effective strategy? Public Health Nutr. 2008;11:632-638.
19. Rouse D. Potential cost-effectiveness of nutrition interventions to prevent adverse pregnancy outcomes in the developing world. J Nutr. 2003;133:S1640-S1644.
20. Romano P, Waitzman N, Scheffler R, etal. Folic acid fortification of graan economic analysis. Am J Public Health. 1995;85:667-676.
21. Llanos A, Hertrampf E, Cortes F, etal. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy. 2007;83:295-303.
22. Bentley T, Weinstein M, Willett W, etal. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr. 2008;12:455-467.
23. Jentink J, van de Vrie-Hoekstra N, de Jong-van den Berg L, etal. Economic evaluation of folic acid food fortification in the Netherlands. Eur J Public Health. 2008;18:270-274.
24. Fiedler J, Macdonald B. A strategic approach to the unfinished fortification agenda: feasibility, costs, and cost-effectiveness analysis of fortification programs in 48 countries. Food Nutr Bull. 2009;30:283-316.
25. Stein A, Meenakshi J, Qaim MPN, etal. Analyzing the Health Benefits of Biofortified Staple Crops by Mean of the Disability-Adjusted Life Years Approach: A Handbook Focusing on Iron, Zinc, and Vitamin A. Technical Monograph 4, Washington, DC: HarvestPlus; 2005.
26. Zimmermann R, Qaim M. Potential health benefits of golden rice: a Philippine case study. Food Policy. 2004;29:147-168.
27. Bouis H. Plant breeding: a new tool for fighting micronutrient malnutrition. J Nutr. 2002;132:S491-S494.
28. Qaim M, Stein A, Meenakshi J. Economics of biofortification. Agric Econ. 2007;37:120-133.
29. Meenakshi J, Johnson N, Manyong V, etal. How cost-effective is biofortification in combating micronutrient malnutrition? An ex ante assessment. World Dev. 2010;38:64-75.
30. Stein AJ, Sachdev HPS, Qaim M. Potential impacts of Golden Rice on public health in India. Contributed paper presented at: International Association of Agricultural Economists Conference; August 12-16, 2006:Gold Coast, Australia.
31. Stein A, Nestel P, Meenakshi J, etal. Plant breeding to control zinc deficiency in India: how cost-effective is biofortification? Public Health Nutr. 2007;10:492-501.
32. Stein A, Meenakshi J, Qaim M, etal. Potential impacts of iron biofortification in India. Soc Sci Med. 2008;66:1797-1808.
33. Dalziel K, Segal L, Katz R. Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand. Public Health Nutr. 2009;13:566-578.
34. Fiedler J, Afidra R. Vitamin A fortification in Uganda: comparing the feasibility, coverage, costs, and cost-effectiveness of fortifying vegetable oil and sugar. Food Nutr Bull. 2010;31:193-205.
35. Manyong VM, Bamire AS, Sanusi IO, etal. Ex-ante evaluation of nutrition and health benefits of biofortified cassava roots in Nigeria: the DALYs approach. Proceedings of the Inaugural Symposium of the African Association of Agricultural Economists; December 6-8, 2004:Nairobi, Kenya.
36. Chow J, Klein E, Laxminarayan R. Cost-effectiveness of "golden mustard" for treating vitamin A deficiency in India. PLoS ONE. 2010;5:e12046.
37. Sharieff W, Zlotkin S, Ungar W, etal. Economics of preventing premature mortality and impaired cognitive development in children through home-fortification: a health policy perspective. Int J Technol Assess Health Care. 2008;24:303-311.
38. Schaible U, Kaufmann S. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007;4:e115.
39. th Ed. New York: Humana Press; 2010:23-50.
40. Frazão E. High Costs of Poor Eating Patterns in the United States. Frazão E, ed. America's Eating Habits: Changes and Consequences. Agriculture Information Bulletin No. AIB750. Washington, DC: U.S. Department of Agriculture, Economic Research Service, Food and Rural Economics Division; 1999:5-32.
41. Oster G, Thompson D. Estimated effects of reducing dietary saturated fat intake on the incidence and costs of coronary heart disease in the United States. J Am Diet Assoc. 1996;96:127-131.
42. Bibbins-Domingo K, Chertow GM, Coxson PG, etal. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362:590-599.
43. Dall T, Fulgoni V, Zhang Y, etal. Potential health benefits and medical cost savings from calorie, sodium, and saturated fat reductions in the American diet. Am J Health Promot. 2009;23:412-422.
44. Dall T, Fulgoni V, Zhang Y, etal. Predicted national productivity implications of calorie and sodium reductions in the American diet. Am J Health Promot. 2009;23:423-430.
45. Asaria P, Chisholm D, Mathers C, etal. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007;370:2044-2053.
46. Smith-Spangler C, Juusola J, Enns E, etal. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis. Ann Intern Med. 2010;152:481-487.
47. McCarron D, Heaney R. Estimated healthcare savings associated with adequate dairy food intake. Am J Hypertens. 2004;17:88-97.
48. rd ed. Totowa, NJ: Humana Press; 2005:383-401.
49. Popkin B, Kim S, Rusev E, etal. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obes Rev. 2006;7:271-293.
50. Avenell A, Broom J, Brown TJ, etal. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess. 2004;8:1-182.
51. Dallongeville J, Dauchet L, de Mouzon O, etal. Increasing fruit and vegetable consumption: a cost-effectiveness analysis of public policies. Eur J Public Health. 2010;21:69-73.
52. Nnoaham KE, Sacks G, Rayner M, etal. Modelling income group differences in the health and economic impacts of targeted food taxes and subsidies. Int J Epidemiol. 2009;38:1324-1333.
53. Marshall T. Exploring a fiscal food policy: the case of diet and ischaemic heart disease. BMJ. 2000;320:301-305.
54. Mytton O, Gray A, Rayner M, etal. Could targeted food taxes improve health? J Epidemiol Community Health. 2007;61:689-694.
55. Cash SB, Sunding DL, Zilberman D. Fat taxes and thin subsidies: prices, diet and health outcomes. Acta Agric Scand C. 2005;2:167-174.
56. Variyam J, Cawley J. Nutrition Labels and Obesity. National Bureau of Economic Research, Cambridge, MA; 2008. Working Paper no. 11956.
57. Magnus A, Haby M, Carter R, etal. The cost-effectiveness of removing television advertising of high-fat and/or high-sugar food and beverages to Australian children. Int J Obes. 2009;33:1094-1102.
58. Gray R, Malla S, Perlich K. Economic impacts of proposed limits on trans fats in Canada. Curr Agric Food Resource Issues. 2006;7:149-161.
59. Sacks G, Veerman J, Moodie M, etal. "Traffic-light" nutrition labelling and "junk-food" tax: a modelled comparison of cost-effectiveness for obesity prevention. Int J Obes (Lond). 2011;35:1001-1009.
60. Rajgopal R, Cox R, Lambur M, etal. Cost-benefit analysis indicates the positive economic benefits of the Expanded Food and Nutrition Education Program related to chronic disease prevention. J Nutr Educ Behav. 2002;34:26-37.
61. Schuster E, Zimmerman Z, Engle M, etal. Investing in Oregon's Expanded Food and Nutrition Education Program (EFNEP): documenting costs and benefits. J Nutr Educ Behav. 2003;35:200-206.
62. Wessman C, Betterley C, Jensen H. An evaluation of the costs and benefits of Iowa's expanded food and nutrition education program (EFNEP). Staff Report 01-SR93. Ames, Iowa: Iowa State University, Center for Agricultural and Rural Development; 2001.
63. Dollahite J, Kenkel D, Thompson S. An economic evaluation of the Expanded Food and Nutrtion Education Program. J Nutr Educ Behav. 2008;40:134-143.
64. Waters HR, Penny ME, Creed-Kanashiro HM, etal. The cost-effectiveness of a child nutrition education programme in Peru. Health Policy Plan. 2006;21:257-264.
65. Gans K, Burkholder G, Risica P, etal. Cost-effectiveness of minimal contact education strategies for cholesterol change. Ethn Dis. 2006;16:443-451.
66. Dalziel K, Segal L, De Lorgeril M. A Mediterranean diet is cost effective in patients with previous myocardial infarction. J Nutr. 2006;136:1879-1885.
67. Panagiotakos D, Sitara M, Pitsavos C, etal. Estimating the 10-year risk of cardiovascular disease and its economic consequences, by the level of adherence to the Mediterranean diet: the ATTICA study. J Med Food. 2007;10:239-243.
68. Daviglus ML, Bell CC, Berrettini W, etal. Preventing Alzheimer's disease and cognitive decline. NIH State-of-the-Science Conference Statement: Preventing Alzheimer's Disease and Cognitive Decline. Vol. 27, no. 4; April 26-28, 2010.
69. Gundgaard J, Nielsen J, Olsen J, etal. Increased intake of fruit and vegetables: estimation of impact in terms of life expectancy and healthcare costs. Public Health Nutr. 2003;6:25-30.
70. Walker D, Aedo C, Albala C, etal. Methods for economic evaluation of a factorial-design cluster randomised controlled trial of a nutrition supplement and an exercise programme among healthy older people living in Santiago, Chile: the CENEX study. BMC Health Serv Res. 2009;9:85-91.
71. Tomson Y, Johannesson M, Aberg H. The costs and effects of two different lipid intervention programmes in primary health care. J Int Med. 1995;237:13-17.
72. Tice JA, Ross E, Coxson PG, etal. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease. JAMA. 2001;286:936-943.
73. Gerber A, Evers T, Haverkamp H, etal. Cost-benefit analysis of a plant sterol containing low-fat margarine for cholesterol reduction. Eur J Health Econ. 2006;7:247-254.
74. Martikainen J, Ottelin A, Kiviniemi V, etal. Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach. Eur J Cardiovasc Prev Rehabil. 2007;14:265-272.
75. Gyles CL, Carlberg JG, Gustafson J, etal. Economic valuation of the potential health benefits from foods enriched with plant sterols in Canada. Food Nutr Res. 2010;54:doi: 10.3402/fnr.v54i0.5113.
76. Malla S, Hobbs J, Perger O. Valuing the health benefits of a novel functional food. Can J Agric Econ. 2007;55:115-136.
77. Schmier J, Rachman N, Halpern M. The cost-effectiveness of omega-3 supplements for prevention of secondary coronary events. Manag Care. 2006;15:43-50.
78. Coyte P. Health Economic Impact Assessment of the Nutritional Effects of Flax: Final Report. Department of Health Policy, Management and Evaluation, and Institute for Policy Analysis. Toronto: University of Toronto; 2005.
79. Agte V, Tarwadi K. The importance of nutrition in the prevention of ocular disease with special reference to cataract. Ophthalmic Res. 2010;44:166-172.
80. Braga M, Gianotti L, Vignali A, etal. Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs. Nutrition 2005;21:1078-1086.
81. Cooper K, Squires H, Carroll C, etal. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol Assess. 2010;14:1-206.
82. Sazawal S, Dhingra U, Hiremath G, etal. Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial. PLoS ONE. 2010;5:e12164.
83. Hickson M, D'Souza AL, Muthu N, etal. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ. 2007;335:80.
84. Guyonnet D, Chassany O, Ducrotte P, etal. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther. 2007;26:475-486.
85. Prescott SL, Bjorksten B. Probiotics for the prevention or treatment of allergic diseases. J Allergy Clin Immunol. 2007;120:255-262.
86. Betsi GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008;9:93-103.
87. Arslanoglu S, Moro GE, Schmitt J, etal. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138:1091-1095.
88. Lenoir-Wijnkoop I, van Aalderen WM, Boehm G, etal. Cost-effectiveness model for a specific mixture of prebiotics in the Netherlands. Eur J Health Econ. 2012;13:101-110.